Skip to main content

Market Overview

Mid-Morning Market Update: Markets Open Higher; AutoZone Beats Q3 Expectations


Following the market opening Tuesday, the Dow traded up 2.29% to 25024.78 while the NASDAQ rose 1.38% to 9453.15. The S&P also rose, gaining 1.77% to 3007.81.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 1,662,760 cases with around 98,220 deaths. Brazil confirmed a total of over 374,890 COVID-19 cases with 23,470 deaths, while Russia reported a total of at least 362,340 confirmed cases and 3,800 deaths. In total, there were at least 5,512,059 cases of COVID-19 worldwide with over 346,610 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Financial shares climbed 3.9% on Tuesday. Meanwhile, top gainers in the sector included Independent Bank Group, Inc. (NASDAQ: IBTX), up 10%, and MGIC Investment Corporation (NYSE: MTG), up 9%.

In trading on Tuesday, health care shares rose by just 0.7%.

Top Headline

AutoZone, Inc. (NYSE: AZO) reported better-than-expected results for its third quarter.

AutoZone reported quarterly earnings of $14.39 per share on Tuesday, which beat the analyst consensus estimate of $13.68 per share. The company reported quarterly sales of $2.80 billion, which beat the analyst consensus estimate of $2.67 billion.

Equities Trading UP

argenx SE (NASDAQ: ARGX) shares shot up 30% to $205.61 after the company disclosed positive topline data from the pivotal ADAPT trial of efgartigimod.

Shares of Fly Leasing Limited (NYSE: FLY) got a boost, shooting 24% to $7.64. JP Morgan upgraded Fly Leasing from Neutral to Overweight and lowered the price target from $17 to $15.

Evofem Biosciences, Inc. (NASDAQ: EVFM) shares were also up, gaining 24% to $6.21 after the company disclosed that the FDA has approved the company’s birth control gel, Phexxi.

Equities Trading DOWN

BioLineRx Ltd. (NASDAQ: BLRX) shares tumbled 31% to $1.65 after the company reported a $9 million registered direct offering.

Shares of Caladrius Biosciences, Inc. (NASDAQ: CLBS) were down 17% to $1.7201 after the company reported a $4.3 million registered direct offering priced at-the-market under Nasdaq rules.

Genetic Technologies Limited (NASDAQ: GENE) was down, falling 16% to $2.02 after the company announced pricing of $8.0 million public offering.


In commodity news, oil traded up 2.3% to $34.01, while gold traded down 0.6% to $1,725.20.

Silver traded up 1% Tuesday to $17.86, while copper rose 1.6% to $2.4235.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 surged 1%, the Spanish Ibex Index rose 1.3%, while Italy’s FTSE MIB Index rose 1.2%. Meanwhile, the German DAX gained 0.9%, and the French CAC 40 climbed 1.3% while UK shares rose 1.3%.


The Chicago Fed National Activity Index dipped to -16.74 in April, versus a revised reading of -4.97 for March.

The S&P Corelogic Case-Shiller home price index rose 3.9% year-over-year in March, versus a 3.5% increase in the earlier month.

The FHFA house price index increased 0.1% for March.

U.S. new home sales gained 0.6% to an annualized rate of 623,000.

The Dallas Fed manufacturing index for May will be released at 10:30 a.m. ET.

The business uncertainty index for May is scheduled for release at 11:00 a.m. ET.

The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.

Federal Reserve Bank of Minneapolis President Neel Kashkari is set to speak at 1:00 p.m. ET.

The Treasury will auction 2-year notes at 1:00 p.m. ET.


Related Articles (AZO + ARGX)

View Comments and Join the Discussion!

Posted-In: Earnings News Penny Stocks Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at